New study maps SARS-CoV-2 and host protein interactions in detail
A new study released as a preprint on the bioRxiv* server has developed a systemic
Severe Acute Respiratory
Researcher find an emergent SARS-CoV-2 variant in California
Researchers have found a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in California,
How likely is SARS-CoV-2 reinfection?
The coronavirus disease 2019 (COVID-19) pandemic has already caused over 117.6 million confirmed cases the
Narrowing down on small molecular inhibitors of SARS-CoV-2 key protease
A recent methodological study by researchers from the University of Luxembourg shows that the combination
Study rethinks the role of ACE2 in SARS-CoV-2 viral entry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel pathogen that emerged in late
Study confirms B.1.1.7 variant of SARS-CoV-2 is more transmissible
A new modeling study published in the journal Science estimates the B.1.1.7 severe acute respiratory
A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo
The ongoing coronavirus disease 2019 (COVID-19) pandemic has spurred intensive vaccine-related research. As yet, no
Researchers conduct large meta-analysis of COVID-19’s neurological manifestations
The global spread of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
SARS-CoV-2 ORF7a mutation limits host immune suppression, finds study
Besides the highly publicized spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a
Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants
By analyzing the cryoEM structures of antibodies against the SARS-CoV-2 virus, researchers report that the